Alzheimer’s R&D is shifting toward disease modification, with amyloid, tau, RNA and immune targets driving trials, partnerships and oral therapy opportunities.Dublin, Sept. (GLOBE NEWSWIRE) -- ...
UW researchers Barbara Bendlin and Fredrico Rey found an association between imidazole propionate and Alzheimer’s, according ...
Evidence for medically transmitted amyloid pathology is mounting, but whether Alzheimer’s disease itself can be transmitted — ...
The “U Ask, U.Va. Answers” speaker series is hosted by the Office of the Vice President for Research with the goal of ...
For more than three decades, amyloid has been the organizing principle of Alzheimer’s disease research. The sticky protein ...
Blood-based biomarker test combining plasma phosphorylated tau 217 (p-tau217) and amyloid beta 1-42 (Aβ1-42) can accurately ...
Among patients with dementia or Alzheimer's disease, some display particularly pronounced anxiety, delusions and severe ...
Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test can detect small amounts of the clumping-prone tau protein and its misfolded pathological forms ...
Potential root cause of Alzheimer’s may have just been discovered - Study suggests Alzheimer’s may not only damage neurons ...
A team from the Altered Molecular Mechanism in Alzheimer's Disease and Dementia laboratory, led by Javier Sáez Valero, a ...
Plasma p-tau217 successfully identified Alzheimer's pathology in several neurodegenerative syndromes. This included disorders not typically associated with Alzheimer's disease, like frontotemporal ...
On the occasion of World Alzheimer’s Day, Mahajan Imaging & Labs hosted an expert webinar on the role of advanced diagnostics in the early evaluation of Alzheimer’s disease, focusing on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results